13.3
Neuphoria Therapeutics Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY26
FY23 – FY26
Assets
(positive)
Change from FY23 to FY26
millions USD
FY23:
FY24:
13.2
FY25:
15.0
FY26:
21.1
(positive)
Change from FY23 to FY26
millions USD
FY23:
15.2
FY24:
14.5
FY25:
13.5
FY26:
7.64
Total assets
Change from FY23 to FY26
millions USD
FY23:
28.6
FY24:
27.6
FY25:
28.6
FY26:
28.7
Liabilities & Equity
(negative)
Change from FY23 to FY26
millions USD
FY23:
2.74
FY24:
3.83
FY25:
4.22
FY26:
0.76
(negative)
Change from FY23 to FY26
millions USD
FY23:
3.81
FY24:
6.33
FY25:
5.37
FY26:
3.35
(positive)
Change from FY23 to FY26
millions USD
FY23:
22.0
FY24:
17.5
FY25:
19.0
FY26:
24.6
Total liabilities & equity
Change from FY23 to FY26
millions USD
FY23:
28.6
FY24:
27.6
FY25:
28.6
FY26:
28.7
All amounts in millions USD